SCHEMBL413500

SCHEMBL413500

CP(C)(=O)OCCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27689138 0.85 PKM (0.36)
SCHEMBL27689139 0.81
SCHEMBL11237347 0.79
SCHEMBL733409 0.79 ALDH1A1 (0.43)
SCHEMBL28068076 0.78 TSHR (0.39)
SCHEMBL29285234 0.78 TSHR (0.50)
SCHEMBL29285237 0.77
SCHEMBL11907935 0.76 CYP3A4 (0.34)
SCHEMBL23772196 0.75
SCHEMBL8923972 0.75 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8981076-B2 Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis CHEMGENES CORPORATION (US) 2015-03-17 US disclosed
US-8541569-B2 Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA CHEMGENES CORPORATION (US) 2013-09-24 US disclosed
US-20130137861-A1 NOVEL METHODS FOR THE SYNTHESIS AND PURIFICATION OF OLIGOMERS AGILENT TECHNOLOGIES, INC. (US) 2013-05-30 US disclosed
US-8431693-B2 Process for desilylation of oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2013-04-30 US disclosed
US-20120065386-A1 SYNTHESIS OF LABILE BASE PROTECTED - MODIFIED DEOXY &amp; MODIFIED RIBO NUCLEOSIDES, CORRESPONDING PHOSPHORAMIDITES AND SUPPORTS AND THEIR USE IN HIGH PURITY OLIGONUCLEOTIDE SYNTHESIS CHEMGENES CORPORATION 2012-03-15 US disclosed
US-8063198-B2 Processes and reagents for desilylation of oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2011-11-22 US disclosed
US-8058448-B2 Processes and reagents for sulfurization of oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2011-11-15 US disclosed
US-20110196145-A1 PROCESS FOR DESILYLATION OF OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2011-08-11 US disclosed
US-20110137010-A1 PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, EFFICIENT RNA SYNTHESIS AND CONVENIENT INTRODUCTION OF 3'-END LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA CHEMGENES CORPORATION (US) 2011-06-09 US disclosed
US-20110015382-A1 Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis CHEMGENES CORPORATION (US) 2011-01-20 US disclosed
US-20090187027-A1 PROCESSES AND REAGENTS FOR SULFURIZATION OF OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2009-07-23 US disclosed
US-20090005549-A1 Processes and Reagents for Desilylation of Oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2009-01-01 US disclosed